Core Viewpoint - The company *ST Zhongji has initiated a pre-restructuring process, aiming to attract both industrial and financial investors to optimize its financial structure and ensure sustainable operations [1][2]. Group 1: Pre-restructuring Process - On July 28, the Sixth Division Intermediate Court issued a "Pre-restructuring Notice" to initiate the pre-restructuring of *ST Zhongji [1]. - The court appointed the Zhongji Health Liquidation Group as the temporary administrator for *ST Zhongji [1]. - The company announced on August 5 that it would publicly recruit restructuring investors to facilitate the pre-restructuring process with Hongse Tomato Company [1]. Group 2: Company Background - *ST Zhongji is a producer of tomato products based in Xinjiang, specializing in large-pack tomato sauce, small-pack tomato products, and lycopene soft capsules [1]. - Hongse Tomato Company is a core asset and main operating entity within the *ST Zhongji system [1]. Group 3: Recruitment of Investors - The recruitment aims to attract industrial and financial investors to leverage their advantages for resource integration, risk mitigation, and optimization of the company's financial and governance structures [1]. - The conditions for potential restructuring investors include having a minimum total asset of 30 billion yuan and an annual revenue of at least 3 billion yuan [2]. Group 4: Financial Performance - *ST Zhongji expects a net loss of 60 million to 90 million yuan for the first half of the year, primarily due to a significant drop in average sales prices despite a 160% increase in sales volume of large-pack tomato sauce [3]. - The company reported a 60% increase in interest expenses due to a rise in total borrowings [3]. Group 5: Previous Transactions - *ST Zhongji previously planned to acquire 100% of Xinjiang New Energy Chemical Co., which would have constituted a major asset restructuring, but the company announced the termination of this transaction due to changes in market conditions and transaction timelines [2].

Core Viewpoint - The company, Zhongji Health Industry Co., Ltd., is undergoing a pre-restructuring process initiated by the court, aiming to recruit restructuring investors to optimize its financial and governance structure while protecting the rights of creditors and stakeholders [1][3][26]. Company Overview - Zhongji Health was established on June 30, 1994, with a registered capital of 771.283579 million yuan and is located in the Xinjiang Uygur Autonomous Region. The company was listed on the Shenzhen Stock Exchange in September 2000, with the stock code 000972 [1]. - The subsidiary, Xinjiang Zhongji Red Tomato Industry Co., Ltd., was founded on December 30, 2008, with a registered capital of 1.4712938 billion yuan, serving as a core asset within the company [2]. Recruitment Purpose - The recruitment aims to attract both industrial and financial investors to leverage their advantages for resource integration, risk mitigation, and optimization of the asset-liability structure, equity structure, and corporate governance, ultimately ensuring sustainable operations and profitability [3]. Investor Requirements - Interested restructuring investors must be legally established entities or individuals with good commercial reputation and no significant legal violations in the past three years. They should also have a clear decision-making process and sufficient financial capability, with a minimum total asset of 30 billion yuan and revenue of at least 3 billion yuan in the last fiscal year [6][7][8]. Recruitment and Selection Process - The registration period for interested investors is until August 22, 2025, with specific documentation required, including a registration intention letter, confidentiality agreement, and proof of financial capability [9][10][18]. - A registration deposit of 30 million yuan is required by the same deadline, which will be returned to unsuccessful applicants within ten working days after the selection results are announced [19][24]. Other Matters - The recruitment process will be conducted in Chinese, and all submitted documents must be in Chinese or accompanied by a Chinese translation [25].

证券代码：000972 证券简称：*ST 中基 公告编号：2025-063 号 中基健康产业股份有限公司 关于公开招募重整投资人的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 2025 年 7 月 28 日，新疆生产建设兵团第六师中级人民法院（以下简称"六师中院"或"法 院"）作出（2025）兵 06 破申（预）1 号《预重整通知书》，启动对中基健康产业股份有限 公司（以下简称"中基健康"或"公司"）的预重整。同日，六师中院出具（2025）兵 06 破 申（预）1 号《确定书》，确定中基健康清算组担任中基健康临时管理人（以下简称"临时管 理人"）。2025 年 7 月 28 日，六师中院作出（2025）兵 06 破申（预）2 号《预重整通知书》， 启动对新疆中基红色番茄产业有限公司（以下简称"红色番茄公司"）的预重整。 为依法推进中基健康与红色番茄公司预重整工作，临时管理人将公开招募重整投资人，现 将招募具体事宜公告如下： 一、公司概况 中基健康成立于 1994 年 6 月 30 日，注册资本 77,128.3579 万元，注册地为新疆维吾尔自 治区五家 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 2025年7月28日，公司收到六师中院送达的《预重整通知书》[（2025）兵06破申（预）1号]，六师中院 通知启动对公司的预重整。同日，红色番茄收到六师中院送达的《预重整通知书》[（2025）兵06破申 （预）2号]，六师中院通知启动对红色番茄的预重整。 公司已于2025年7月29日披露了《关于公司及下属全资子公司被债权人申请重整与预重整暨法院启动预 重整并指定临时管理人的公告》（公告编号：2025-060号）。 根据《深圳证券交易所股票上市规则（2025年修订）》和《深圳证券交易所上市公司自律监管指引第14 号一一破产重整等事项（2025年修订）》规定，公司对是否涉及被深圳证券交易所强制退市行为的情 况、控股股东、实际控制人及其他关联方资金占用、对外担保、承诺履行情况等事项进行了全面自查。 现将具体情况说明如下： 证券代码：000972 证券简称：*ST中基 公告编号：2025-061号 中基健康产业股份有限公司 关于公司及下属全资子公司被债权人申请重整及预重整的专项自查报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或 ...

金融界消息 截至2025年7月29日收盘，*ST中基（000972）报收于3.29元，下跌0.6%，换手率5.62%，成 交量43.34万手，成交金额1.46亿元。 资金流向方面，今日主力资金净流出2169.95万元，占比成交额14.87%。其中，超大单净流出796.94万 元、占成交额5.46%，大单净流出1373.01万元、占成交额9.41%，中单净流出流入1189.33万元、占成交 额8.15%，小单净流入980.62万元、占成交额6.72%。 *ST中基最新一期业绩显示，截至2025一季报，公司营业总收入7869.34万元、同比减少34.01%，归属净 利润725.57万元，同比减少221.28%，扣非净利润788.31万元，同比减少283.60%，流动比率0.790、速动 比率0.148、资产负债率101.54%。 天眼查商业履历信息显示，中基健康产业股份有限公司，成立于1994年，位于自治区直辖县级行政区 划，是一家以从事资本市场服务为主的企业。企业注册资本77128.3579万人民币，实缴资本1200万人民 币。公司法定代表人为王长江。 通过天眼查大数据分析，中基健康产业股份有限公司共对外投资了 ...

证券代码：000972 证券简称：*ST 中基 公告编号：2025-061 号 中基健康产业股份有限公司 关于公司及下属全资子公司被债权人申请重整及预重整的专项自查报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 中基健康产业股份有限公司（以下简称"公司"）于近日获悉，中兴财光华会计师事务所 （特殊普通合伙）（以下简称"中兴财光华"）以公司不能清偿到期债务且明显缺乏清偿能力， 但具有重整价值为由，于 2025 年 7 月 25 日向新疆生产建设兵团第六师中级人民法院（以下简 称"六师中院"或"法院"）申请对公司进行重整及预重整，并提交了相关材料。 截至本报告披露日，公司不存在因涉及国家安全、公共安全、生态安全、生产安全和公众 健康安全等领域的重大违法行为而导致股票可能被终止上市的情形。 公司下属全资子公司新疆中基红色番茄产业有限公司（以下简称"红色番茄"）于近日获 悉，新疆恒源水务有限公司（以下简称"恒源水务"）以红色番茄不能清偿到期债务且明显缺 乏清偿能力，但具有重整价值为由，于 2025 年 7 月 25 日向六师中院申请对红色番茄进行重整 及预重整，并 ...

证券代码：000972 证券简称：*ST 中基 公告编号：2025-062 号 中基健康产业股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 2025 年 7 月 28 日，中基健康产业股份有限公司（以下简称"公司"）及公司下属全资子 公司新疆中基红色番茄产业有限公司（以下简称"红色番茄"）分别收到新疆生产建设兵团第 六师中级人民法院（以下简称"六师中院"或"法院"）送达的《预重整通知书》[（2025） 兵 06 破申（预）1 号、（2025）兵 06 破申（预）2 号]。六师中院通知启动对公司及红色番茄 的预重整，并指定公司清算组担任公司临时管理人、红色番茄清算组担任红色番茄临时管理人 （以下合称"临时管理人"）。 现临时管理人就公司及子公司红色番茄预重整期间债权申报的相关内容公告如下： 一、债权申报期间及内容 公司及子公司红色番茄的债权人应于 2025 年 8 月 28 日（含当日）前向临时管理人申报债 权，书面说明债权人基本信息、债权的形成过程、债权金额（包括本金数额、截至预重整之日 的孳息数额、孳息计算方法和利息清单等）、有无财产担保、是否为 ...

Core Viewpoint - Zhongji Health Industry Co., Ltd. and its wholly-owned subsidiary, Xinjiang Zhongji Red Tomato Industry Co., Ltd., have been applied for reorganization and pre-reorganization by creditors due to their inability to repay debts and lack of repayment capacity, but they possess reorganization value [1][2][3] Group 1: Company Overview - Zhongji Health Industry Co., Ltd. has been facing financial difficulties, with total assets of approximately 1.62 billion yuan and total liabilities of about 1.64 billion yuan as of March 31, 2025 [6] - The company reported a net profit of -725.57 million yuan for the first quarter of 2025, and its annual net profit for 2024 was -2.31 billion yuan [6][13] - The subsidiary, Xinjiang Zhongji Red Tomato Industry Co., Ltd., also reported significant losses, with a net profit of -713.03 million yuan for the first quarter of 2025 [7] Group 2: Legal Proceedings - On July 25, 2025, Zhongji Health and its subsidiary were applied for pre-reorganization by creditors, with the court officially notifying the initiation of pre-reorganization on July 28, 2025 [2][8] - The court has appointed a temporary management team to oversee the reorganization process, which includes investigating the debtor's financial situation and supervising asset management [9][10] Group 3: Financial Impact - The company has been under "delisting risk warning" since April 1, 2025, due to negative net assets and insufficient revenue [13][14] - The ongoing pre-reorganization does not guarantee that the court will accept the reorganization applications, and the future of the company remains uncertain [11][12]

证券代码：000972 证券简称：*ST 中基 公告编号：2025-060 号 中基健康产业股份有限公司 关于公司及下属全资子公司被债权人申请重整与预重整 暨法院启动预重整并指定临时管理人的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 特别提示： 1、中基健康产业股份有限公司（以下简称"公司"）于近日获悉，中兴财光华会计师事务 所（特殊普通合伙）（以下简称"中兴财光华"）以公司不能清偿到期债务且明显缺乏清偿 能力，但具有重整价值为由，于 2025 年 7 月 25 日向新疆生产建设兵团第六师中级人民法院 （以下简称"六师中院"或"法院"）申请对公司进行重整及预重整，并提交了相关材料。 公司下属全资子公司新疆中基红色番茄产业有限公司（以下简称"红色番茄"）于近日获悉， 新疆恒源水务有限公司（以下简称"恒源水务"）以红色番茄不能清偿到期债务且明显缺乏 清偿能力，但具有重整价值为由，于 2025 年 7 月 25 日向六师中院申请对红色番茄进行重整及 预重整，并提交了相关材料。 2、2025 年 7 月 28 日，公司收到六师中院送达的《预重整通知书》[（20 ...

Group 1: M&A Activity Overview - From July 14 to July 20, there were 77 M&A events involving listed companies, with 27 classified as significant M&A transactions[9] - Out of the total M&A events, 12 were completed, including 1 significant M&A transaction involving Baota Industrial[9] - There were 3 failed M&A attempts by listed companies, specifically by Lixing Co., Hongming Co., and Zhongji Health[15] Group 2: Policy Updates - On July 18, Tianjin's financial authorities released measures to support M&A, focusing on 12 key industrial chains and establishing a resource pool for quality M&A targets[7] - The Shanghai G60 Science and Technology Innovation Group held a summit on July 16 to discuss M&A and overseas expansion in the context of innovation and industry leadership[7] Group 3: Market Performance - During the week of July 14 to July 20, the restructuring index outperformed the Wind All A index by 0.27%[19] - Over a mid-term view, the restructuring index's rolling 20-day return shifted from negative to positive compared to the Wind All A index[19] Group 4: Control Changes - Two listed companies reported changes in actual control during this period, with Shenjian Co. and Hualan Group undergoing ownership transitions[17]